🇺🇸 FDA
Pipeline program

Avatrombopag 20 MG Oral Tablet

IIT2021008-EC-1(2)

Unknown small_molecule active

Quick answer

Avatrombopag 20 MG Oral Tablet for Aplastic Anemia is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Aplastic Anemia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials